If certain key, evidence-based principles are followed, remission is now an achievable goal in asthma treatment. First, it is recommended to routinely supplement spirometry with a blood test to measure eosinophil counts, as this has proven to be an extremely important biomarker. Second, bronchodilator therapy should be combined with anti-inflammatory therapy; highly effective biologics are now available for severe asthma. Third, long-term asthma control is essential, involving the monitoring of progression parameters such as eosinophil count and FeNO and, if necessary, adjustment of therapy.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Orthobiologics for knee osteoarthritis
PRP and hyaluronic acid injections as building blocks in a multimodal concept
- Soft tissue sarcomas of the lower extremity
Diagnostics, subtypes and treatment options
- Psychological dependence on AI assistants, smartphones and short videos
Algorithms, avatars and the unburdened mind
- Psychooncology
Communication as the key to therapy adherence
- The Brain and the Motivation to Eat
Why is it so hard to lose weight?
- Omaveloxolone for Friedreich's Ataxia
Efficacy and Safety Studied Over 6 Years
- Psoriasis: therapy with biologics and TYK-2-i
Progress assessments based on current long-term and real-world data
- Hypertension: the most important facts for daily practice